Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization
•Many patients hospitalized for COVID-19 suffer from long-term health problems.•In-hospital treatment for COVID-19 is not associated with long-term health outcomes.•Additional research is recommended to explore pharmacological treatments for long COVID. Various mechanisms, such as immune dysregulati...
Gespeichert in:
Veröffentlicht in: | International journal of infectious diseases 2024-05, Vol.142, p.106966-106966, Article 106966 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Many patients hospitalized for COVID-19 suffer from long-term health problems.•In-hospital treatment for COVID-19 is not associated with long-term health outcomes.•Additional research is recommended to explore pharmacological treatments for long COVID.
Various mechanisms, such as immune dysregulation, viral reservoir, and auto-immunity, are hypothesized to underlie the pathogenesis of long-term health problems after hospitalization for COVID-19. We aimed to assess the effect of in-hospital COVID-19 treatments on prominent long-term health problems.
In this prospective multicenter cohort study, we enrolled patients (age ≥18 years) who had been hospitalized for COVID-19 in the Netherlands between July 2020 and October 2021. We retrospectively collected data on in-hospital COVID-19 treatments, including steroid, anti-inflammatory, and antiviral treatments. Patients completed questionnaires on self-reported recovery, dyspnea, fatigue, cognitive failures, and health-related quality of life and performed the 6-minute walk test at the 2-year follow-up visit.
Five hundred two patients with COVID-19 were included, all were discharged from the hospital between March 2020 and June 2021. The median age at admission was 60.0 (IQR 53.0-68.0) years and 350 (69.7%) patients were male. At hospital admission, 5/405 (1.2%) of the patients had been vaccinated against SARS-CoV-2. Among all 502 patients, the majority (248 [49.4%]) received steroids only, 57 (11.4%) anti-inflammatory treatment, 78 (15.5%) antiviral treatment, and 119 (23.7%) none during hospitalization. Long-term health problems were common in all groups. We found that in-hospital treatments were not significantly associated with health problems at 2 years after hospital discharge, nor after adjusting for confounders.
Many patients with COVID-19 suffer from long-term health problems 2 years after hospital discharge. Acute treatment for COVID-19 is not associated with long-term health problems. |
---|---|
ISSN: | 1201-9712 1878-3511 |
DOI: | 10.1016/j.ijid.2024.02.009 |